Should I buy or sell Shanghai Fosun Pharmaceutical (Group) stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shanghai Fosun Pharmaceutical (Group) in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SFOSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SFOSF, but not buy additional shares or sell existing shares. View SFOSF analyst ratings or view top-rated stocks .

How have SFOSF shares performed in 2024?

Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $2.19 at the beginning of the year. Since then, SFOSF stock has decreased by 27.4% and is now trading at $1.59. View the best growth stocks for 2024 here .

Are investors shorting Shanghai Fosun Pharmaceutical (Group)?

Shanghai Fosun Pharmaceutical (Group) saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,896,700 shares, an increase of 53.6% from the March 31st total of 1,886,200 shares. Based on an average trading volume of 5,100 shares, the short-interest ratio is presently 568.0 days. View Shanghai Fosun Pharmaceutical (Group)'s Short Interest .

Is Shanghai Fosun Pharmaceutical (Group) a good dividend stock?

Shanghai Fosun Pharmaceutical (Group) (OTCMKTS:SFOSF) pays an annual dividend of $0.27 per share and currently has a dividend yield of 1.21%. The dividend payout ratio is 23.08%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Shanghai Fosun Pharmaceutical (Group)?

Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SFOSF

Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis

→ The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad)

Free SFOSF Stock Alerts

$1.59

0.00 (0.00%)

(As of 05/7/2024 ET)

Compare

Today's Range: $1.59
▼
$1.59
50-Day Range: $1.52
▼
$1.90
52-Week Range: $1.52
▼
$2.92

Volume: N/A
Average Volume: 9,895 shs
Market Capitalization: N/A

P/E Ratio: 1.36
Dividend Yield: 16.98%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Shanghai Fosun Pharmaceutical (Group) alerts:

Ad Gold Safe Exchange

Gold Set to EXPLODE!

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

SFOSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SFOSF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive SFOSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shanghai Fosun Pharmaceutical (Group) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: OTCMKTS:SFOSF
CUSIP: N/A
CIK: N/A
Web: www.fosunpharma.com
Phone: 86-21-3398-7000
Fax: N/A
Employees: 40,370
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 1.36
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Kexin Wang (Age 59)
Executive Co-Chairman
Comp: $2.69M
Mr. Yifang Wu (Age 55)
Executive Chairman
Comp: $1.75M
Mr. Deyong Wen (Age 53)
Joint President,CEO & Executive Director
Comp: $1.1M
Ms. Xiaohui Guan (Age 53)
Executive Vice Chairman
Comp: $1.2M
Mr. Shengli Li (Age 50)
Executive President & Chief Growth Officer
Ms. Rongli Feng (Age 49)
Executive President, Chief Human Resources Officer & GM of Human Resources Department
Ms. Jing Li (Age 52)
Executive President and CEO of Established Medicines Manufacturing & Supply Division
Mr. Wang Xingli M.D. (Age 62)
Ph.D., Executive President, Co-CEO of Innovative Medicines Division and CEO of Global R&D Center
Mr. Wenjie Zhang (Age 57)
Executive President & Co-CEO of Innovative Drug Division
Ms. Xiaolei Wu (Age 44)
VP & CFO

Key Competitors

View All Competitors

SFOSF Stock Analysis - Frequently Asked Questions

Should I buy or sell Shanghai Fosun Pharmaceutical (Group) stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shanghai Fosun Pharmaceutical (Group) in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SFOSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SFOSF, but not buy additional shares or sell existing shares.
View SFOSF analyst ratings or view top-rated stocks.
How have SFOSF shares performed in 2024?: Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $2.19 at the beginning of the year. Since then, SFOSF stock has decreased by 27.4% and is now trading at $1.59.
View the best growth stocks for 2024 here.
Are investors shorting Shanghai Fosun Pharmaceutical (Group)?: Shanghai Fosun Pharmaceutical (Group) saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,896,700 shares, an increase of 53.6% from the March 31st total of 1,886,200 shares. Based on an average trading volume of 5,100 shares, the short-interest ratio is presently 568.0 days.
View Shanghai Fosun Pharmaceutical (Group)'s Short Interest.

Is Shanghai Fosun Pharmaceutical (Group) a good dividend stock?: Shanghai Fosun Pharmaceutical (Group) (OTCMKTS:SFOSF) pays an annual dividend of $0.27 per share and currently has a dividend yield of 1.21%. The dividend payout ratio is 23.08%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Shanghai Fosun Pharmaceutical (Group)?: Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SFOSF) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial